Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
Combination of venetoclax and azacitidine helps patients with AML who relapse after hematopoietic cell transplant
2024-07-18
(Press-News.org)
Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs and frailty of the patient’s organ functions. A type of anti-tumor immunotherapy called allogeneic hematopoietic cell transplantation, which can exert anti-cancer effect accompanied by severe toxicity, is often performed for patients who are hard to treat with chemotherapy, but relapse still remains.
The hematopoietic cell transplant team in Osaka Metropolitan University Graduate School of Medicine has developed a novel strategy using a new drug combination, which demonstrated significant anti-cancer effect with mild toxicity for relapsed/refractory AML patients. In addition, the detailed immunological study showed how a new drug induced the enhancement of anti-cancer activity via alterations of immune cells.
In correspondence published in the Nature-affiliated Blood Cancer Journal, the researchers report on their clinical observational study using venetoclax in combination with azacitidine as the treatment for 12 patients with AML who relapsed after allogeneic hematopoietic cell transplantation.
Venetoclax is an oral medication developed by AbbVie and Roche that was approved by the U.S. Food and Drug Administration in October 2020 for AML. It has shown promising results for older patients with untreated AML in promoting the death of cancer cells by inhibiting a regulator protein known as BCL-2.
The OMU researchers’ study showed markedly better survival rates after one year for the venetoclax combination therapy group than a control group of 61 patients, at 66.7% to 27.3%. They also showed in the immunological study that the alterations of immune cells induced by venetoclax had enhanced the anti-tumor activity.
“This study demonstrates that novel therapy can improve the prognosis of relapsed/refractory acute myeloid leukemia through both clinical and basic approaches. This therapy can be applied to more patients because of the reduction of the treatment burden,” proclaimed Dr. Mitsutaka Nishimoto, the corresponding author. “We hope this will lead to the development of safer, more effective treatments.”
###
About OMU
Established in Osaka as one of the largest public universities in Japan, Osaka Metropolitan University is committed to shaping the future of society through “Convergence of Knowledge” and the promotion of world-class research. For more research news, visit https://www.omu.ac.jp/en/ and follow us on social media: X, Facebook, Instagram, LinkedIn.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-07-18
Almost 2,000 years ago, Pliny the Younger wrote letters describing a shaking ground as Vesuvius erupted. Now, a collaborative study led by researchers from the Istituto Nazionale di Geofisica e Vulcanologia (INGV) and Pompeii Archaeological Park has shed light on the effects of seismicity associated with the 79CE eruption.
The study is the first to tackle the complex task of reporting on the effects of co-occurring earthquakes. This is tricky due to the possibility of volcanic and seismic effects happening concurrently or in quick succession, meaning volcanic effects can overshadow effects caused by earthquakes and vice versa.
“These ...
2024-07-18
18 July 2024: Britain’s largest ever study of egg freezing which followed up the outcome of almost 30,000 eggs frozen at the London Women’s Clinic shows that success rates are comparable to those achieved by routine IVF and subject to the same variables of female age and embryo quality.(1) When seen alongside other similar large-scale egg-freezing studies from other countries, the results of this study add to a pattern of success which is consistent, predictable and reliable.
The study, published today in the peer-reviewed journal Reproductive Biomedicine Online, analysed the outcomes of treatment ...
2024-07-18
With the promotion of carbon neutrality and carbon peaking goals, the construction of low-carbon cities and related quantitative assessments have become hot topics in the field of urban planning and design. The Intergovernmental Panel on Climate Change (IPCC) points out that the net emissions of anthropogenic greenhouse gases have continued to rise over the past decade, with the average annual emissions higher than any previous decade. Without additional climate change mitigation policies, global warming could lead to a temperature increase of 3.5°C ...
2024-07-18
A pioneering study led by Baylor University biologist Sarah Kienle, Ph.D., and published in the journal Polar Biology has unveiled the first paired observations of sexual behavior and vocalizations in wild leopard seals. Supported by a grant from the National Science Foundation, Kienle and her team’s third published study on the mysterious leopard seal represents a major advance in understanding the behavior of one of the most difficult apex predators to study on Earth.
Key findings from the study
Kienle and her team observed a two-hour courtship interaction between a male and female leopard seal in Laguna San Rafael, Chile, and documented a range of behaviors ...
2024-07-18
Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed that testing for viral drug resistance could improve treatment in cases where treatment has failed. However, a research team led by the University of Basel, Switzerland, now shows that it is much more important to support patients in taking their medication regularly.
The fight against HIV has made great strides over the past few decades. Antiretroviral drugs keep the virus at bay, preventing ...
2024-07-18
The number of adults in England who report vaping for more than six months has increased substantially from around one in 80 in 2013 to one in 10 in 2023, finds a study published by The BMJ today.
Much of this increase has occurred since 2021, coinciding with the rapid rise in popularity of disposable e-cigarettes, especially among young adults, including those who had never regularly smoked, the results show.
It was already established that vaping rates have increased substantially in England since new disposable e-cigarettes became ...
2024-07-18
Neither covid-19 infection nor vaccination during the first trimester of pregnancy is associated with increased risk of major birth defects, finds a study from Scandinavia published by The BMJ today.
It’s well known that women who experience covid-19 infection during pregnancy are at increased risk of severe illness and have a higher risk of complications, including preterm birth and stillbirth.
Less clear is the risk of birth defects (congenital anomalies) after infection with or vaccination against covid-19 as it has only recently become ...
2024-07-18
Some of the UK’s most recognisable TV doctors are increasingly being “deepfaked” in videos to sell scam products across social media, finds The BMJ today.
Trusted names including Hilary Jones, Michael Mosley and Rangan Chatterjee are being used to promote products claiming to fix high blood pressure and diabetes, and to sell hemp gummies, explains journalist Chris Stokel-Walker.
Deepfaking is the use of artificial intelligence (AI) to map a digital likeness of a real-life human being onto a video of a body that isn’t theirs. Reliable evidence on how ...
2024-07-18
A new collaboration between researchers from the Netherlands Institute for Neuroscience, the University of Amsterdam and the University of Chieti explores the neural substrates of blushing in a MRI scanner.
Most of us know what it feels like to blush. The face becomes warm and red, and we experience self-conscious emotions, such as embarrassment, shyness, shame, and pride. It is perhaps no wonder that Charles Darwin referred to it as “the most peculiar and the most human of all expressions”. But why do we blush, and what ...
2024-07-18
The introduction of new data protection rules significantly reduced breaches by firms but negatively impacted their market value, according to new research by the University of East Anglia (UEA) and University of Texas.
Researchers looked at what happened when the European Union’s General Data Protection Regulation (GDPR) started being enforced in 2018. Using its extraterritorial reach, the authors explore variation in US firms’ exposure to the EU GDPR to see how stricter data privacy laws affected their value, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
Combination of venetoclax and azacitidine helps patients with AML who relapse after hematopoietic cell transplant
